Enciprazine |
||
| Identification | ||
| Name | Enciprazine | |
| CAS Registry Number | 68576-86-3 | |
| Synonyms | ||
| Molecular Structure |
|
|
| Molecular Formula | ||
| Molecular Weight | ||
|
|
|
| Clinical data | |
|---|---|
|
Routes of
administration |
Oral |
| Identifiers | |
|
IUPAC name
|
|
| Synonyms | WY-48624; D-3112 |
| CAS Number |
|
| PubChem CID |
|
| ChemSpider |
|
| UNII |
|
| KEGG |
|
| ChEMBL |
|
| Chemical and physical data | |
| Formula | C 23 H 32 N 2 O 6 |
| Molar mass | 432.52 g·mol −1 |
| 3D model (JSmol) |
|
|
SMILES
|
|
|
InChI
|
|
Enciprazine (INN, BAN; enciprazine hydrochloride (USAN); developmental code names WY-48624 , D-3112 ), is an anxiolytic and antipsychotic of the phenylpiperazine class which was never marketed. [1] [2] [3] [4] It shows high affinity for the α 1 -adrenergic receptor and 5-HT 1A receptor, among other sites. [3] [5] [6] The drug was initially anticipated to produce ortho -methoxyphenylpiperazine (oMPP), a serotonin receptor agonist with high affinity for the 5-HT 1A receptor, as a significant active metabolite, but subsequent research found this not to be the case. [5]